Education
About Us
Working with TipRanks
Follow Us
John Niederhuber Insider Profile
4 Followers
John Niederhuber, Director at Emergent Biosolutions, holds 217.00 shares in Aptevo Therapeutics (Ticker: APVO), holds 30.30K shares in Emergent Biosolutions (Ticker: EBS).
John Niederhuber has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Niederhuber holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 03, 2022 - Jun 03, 2023
Return:-67.90%
The most profitable trade made by John Niederhuber
John Niederhuber's Trading History
Emergent Biosolutions
May 20, 2016
Director
Uninformative Sell
―
$174.83K
Aptevo Therapeutics
Jun 03, 2024
Director
Uninformative Buy
62.65
$551.18
List of latest transactions for each holding click on a transaction to see John Niederhuber's performance on stock
You May Also Like
John Niederhuber insider profile FAQ
What is the percentage of profitable transactions made by John Niederhuber?
The percentage of profitable transactions made by John Niederhuber is ―.
What is the average return per transaction made by John Niederhuber?
The average return per transaction made by John Niederhuber is ―.
What stocks does John Niederhuber hold?
John Niederhuber holds: EBS, APVO stocks.
What was John Niederhuber’s latest transaction?
John Niederhuber latest transaction was an Uninformative Buy of $62.65.
What was John Niederhuber's most profitable transaction?
John Niederhuber’s most profitable transaction was an Informative Buy of APVO stock on June 3, 2022. The return on the trade was -67.90%.
What is John Niederhuber's role in Emergent Biosolutions?
John Niederhuber's role in Emergent Biosolutions is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.